Full Text View
Tabular View
No Study Results Posted
Related Studies
Genetics of Coronary Artery Disease in Alaskan Natives (GOCADAN)
This study has been completed.
First Received: August 31, 2000   Last Updated: May 1, 2009   History of Changes
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00006192
  Purpose

To document cardiovascular disease and cardiovascular disease risk factors among 1,200 Native Alaskans who are members of approximately 40 families.


Condition Phase
Heart Diseases
Cardiovascular Diseases
Atherosclerosis
Hypertension
Diabetes Mellitus
Coronary Arteriosclerosis
N/A

MedlinePlus related topics: Coronary Artery Disease Diabetes Heart Diseases High Blood Pressure
U.S. FDA Resources
Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: August 2000
Study Completion Date: December 2005
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Detailed Description:

BACKGROUND:

There are many compelling reasons to study heart disease in the Native Alaskans. These Eskimo villages are remote and isolated. The traditional lifestyle is being eroded by mechanization and a westernized diet. There has been relatively little outside genetic influence and they are, like the American Indians of the lower 48 states, beginning to show a marked acceleration in the prevalence of atherosclerosis and coronary artery disease.

DESIGN NARRATIVE:

The study is a family-based, cross sectional study. Recognized and emerging risk factors and prevalent cardiovascular disease are documented in each individual through a standardized interview, physical exam, laboratory measurements, carotid ultrasound, ECG, and a review of centralized medical records. Assays will be made of contemporary samples and serum specimens stored at the Anchorage Center CDC antedating this study (10 to 20 years ago) for specific markers of inflammation and serologic responses. Through a ten-centimorgan genetic map, attempts will be made to find specific genes that relate to cardiovascular disease.

The study uses standard methods to assess risk factors relating to lipid metabolism, hypertension, and diabetes mellitus. Importantly, the study also uses state-of-the-art methods for detection of infectious disease exposure, specifically to C. pneumoniae, cytomegalovirus, and other infectious agents hypothesized to play a role in atherogenesis. A case-control age-matched design is used to analyze the infectious disease burden.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

No eligibility criteria

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00006192

Sponsors and Collaborators
Investigators
Investigator: Giacomo Ruotolo Medstar Research Institute
  More Information

Publications:
Study ID Numbers: 910
Study First Received: August 31, 2000
Last Updated: May 1, 2009
ClinicalTrials.gov Identifier: NCT00006192     History of Changes
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Atherosclerosis
Arterial Occlusive Diseases
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Arteriosclerosis
Ischemia
Coronary Disease
Endocrinopathy
Glucose Metabolism Disorders
Metabolic Disorder
Coronary Artery Disease
Hypertension

Additional relevant MeSH terms:
Atherosclerosis
Arterial Occlusive Diseases
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Arteriosclerosis
Coronary Disease
Cardiovascular Diseases
Glucose Metabolism Disorders
Coronary Artery Disease
Hypertension

ClinicalTrials.gov processed this record on May 06, 2009